Literature DB >> 7664656

Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration.

P P Banerjee1, S Banerjee, K I Tilly, J L Tilly, T R Brown, B R Zirkin.   

Abstract

It is well established that androgens are central to regulation of the growth of the mammalian prostate gland. Conversely, androgen deprivation by castration induces rapid cell death in the ventral prostate via an apoptotic mechanism. To date, most studies of cell death in the rodent prostate have focused on the ventral lobe, with little attention directed to the dorsal and lateral lobes. The results presented herein demonstrate that cell death in the rat prostate gland caused by castration is lobe specific. In particular, castration caused decreases in wet weights and protein contents of all three prostatic lobes, but these events were more rapid and profound in the ventral than in the dorsal and lateral lobes. Reduced epithelial cell size was apparent in the three lobes as well. However, castration resulted in loss of DNA content in the ventral lobe only. To confirm this finding, and to examine apoptosis of individual cells, we used in situ labeling of fragmented DNA, supported by biochemical analysis of DNA integrity in agarose gels. With both approaches, significant cell death in response to castration was seen in the ventral lobe but not the dorsal and lateral lobes. Taken together, these results clearly indicate that there are lobe-specific differences in the response of the rat prostate to androgen ablation by castration, with apoptotic cell death occurring in the ventral lobe of the prostate but to a far lesser extent, if at all, in the dorsal and lateral lobes. Moreover, castration caused apoptotic death of both epithelial and stromal cells of the ventral prostate, with these cells dying throughout the ductal network of the ventral prostate rather than being restricted to a particular region. We suggest that lobe-specific differences in androgen responsiveness in the rat prostate may provide an appropriate model for the study of androgen-independent prostatic cell survival during tumor progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664656     DOI: 10.1210/endo.136.10.7664656

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

Review 2.  Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.

Authors:  Yu-Ching Peng; Alexandra L Joyner
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

3.  Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.

Authors:  Mugdha D Samant; Courtney M Jackson; Carina L Felix; Anthony J Jones; David W Goodrich; Barbara A Foster; Wendy J Huss
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

4.  Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.

Authors:  J DiGiovanni; K Kiguchi; A Frijhoff; E Wilker; D K Bol; L Beltrán; S Moats; A Ramirez; J Jorcano; C Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 5.  Androgen deprivation and immunotherapy for the treatment of prostate cancer.

Authors:  Melissa Gamat; Douglas G McNeel
Journal:  Endocr Relat Cancer       Date:  2017-08-16       Impact factor: 5.678

Review 6.  Androgen action in prostate function and disease.

Authors:  Partha P Banerjee; Subhadra Banerjee; Terry R Brown; Barry R Zirkin
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

7.  Differential age-associated regulation of clusterin expression in prostate lobes of brown Norway rats.

Authors:  Josephat Omwancha; Matthew D Anway; Terry R Brown
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

8.  Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

Authors:  S M Ho; I Leav; S Ghatak; F Merk; V S Jagannathan; K Mallery
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis.

Authors:  David Vindrieux; Marie Réveiller; Jacqueline Chantepie; Sadok Yakoub; Catherine Deschildre; Alain Ruffion; Marian Devonec; Mohamed Benahmed; Renée Grataroli
Journal:  Cancer Cell Int       Date:  2011-12-02       Impact factor: 5.722

10.  In vivo MRI volumetric measurement of prostate regression and growth in mice.

Authors:  Kent L Nastiuk; Hui Liu; Mark Hamamura; L Tugan Muftuler; Orhan Nalcioglu; John J Krolewski
Journal:  BMC Urol       Date:  2007-07-24       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.